In vitro cytotoxicity of mitoxantrone-incorporated albumin microspheres on acute promyelocytic leukaemia cells

References

• BAMBA, M., PUISIEUX, F., MARTY, J. P. and CARSTENSEN, J. T., 1979, Release mechanisms in gel forming sustained release preparations. International Journal of Pharmaceutics, 2, 307–315.
   Google Scholar
• BURGESS, D. J., DAVIS, S. S. and TOMLINSON, E., 1987, Potential use of albumin microspheres as a drug delivery system. I. Preparation and in vitro release of steroids. International Journal of Pharmaceutics, 39, 129–136.
   Google Scholar
• COTTER, F. E., 1988, Therepeutic milestones. Novantrone(mitozantrone). The British Journal of Clinical Practice, 42, 207–209.
   PubMedGoogle Scholar
• EGBERIA, R. and FRIEDMAN, M., 1990, Sustained release albumin microspheres containing antibacterial drugs: effects of preparation conditions on kinetics of drug release. Journal of Controlled Release, 14, 79–94.
   Google Scholar
• GUPTA, P. K., HUNG, C. T. and LAM, F. C., 1989, Factorial design based optimization of the formulation of albumin microspheres containing adriamycin. Journal of Microencapsulation, 6, 147–160.
   PubMedGoogle Scholar
• GUPTA, P. K., HUNG, C. T. and LAM, F. C., 1990, Application of regression analysis in the evaluation of tumor response following the administration of adriamycin either as a solution or via albumin microspheres to the rat. Journal of Pharmaceutical Sciences, 79, 634–637.
   PubMedGoogle Scholar
• HANSEN, M. B., NIELSEN, S. E., and BERG, K., 1989, Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. Journal of Immunological Methods, 119, 203–210.
   PubMedGoogle Scholar
• HIGUCHI, T., 1963, Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrix. Journal of Pharmaceutical Sciences, 52, 1145–1149.
   PubMed Web of Science ®Google Scholar
• Hu, O. Y.-P., CHANG, S.-P., SONG, Y.-B., CHEN, K.-Y., and LAW, C.-K., 1990, Novel assay method for mitoxantrone in plasma, and its application in cancer patients. Journal of Chromatography, 532, 337–350.
   Google Scholar
• LANGER, R., 1990, New methods of drug delivery. Science, 249, 1527–1533.
   PubMed Web of Science ®Google Scholar
• LUFTENSTEINER, C. P., and VIERNSTEIN, H., 1998, Statistical experimental design based studies on placebo and mitoxantrone-loaded albumin microspheres. International Journal of Pharmaceutics, 171, 87–99.
   Google Scholar
• LUFTENSTEINER, C. P., SCHWENDENWEIN, I., PAUL, B., EICHLER, H. G., and VIERNSTEIN, H., 1999, Evaluation of mitoxantrone-loaded albumin microspheres following intraperitoneal administration to rats. Journal of Controlled Release, 57, 35–44.
   PubMedGoogle Scholar
• MAYSINGER, D., ZORC, B., BATULA, I., and JALSENJAK, I., 1990, Preparation and in vivo effect of microencapsulated cholinotoxin. International Journal of Pharmaceutics, 63, 149–153.
   Google Scholar
• NASTRUZZI, C., PASTESINI, C., CORTESI, R., ESPOSITO, E., GAMBARI, R., and MENEGATTI, E., 1994, Production and in vitro evaluation of gelatin microspheres containing an antitumor tetra-amidine. Journal of Microencapsulation, 11, 249–260.
   PubMedGoogle Scholar
• OHYA, Y., TAKEI, T., KOBAYASHI, H., and Oucm, T., 1993, Release behaviour of 5-fluorouracil from chitosan-gel microspheres immobilizing 5-fluorouracil derivative coated with polysaccharides and their cell specific recognition. Journal of Microencapsulation, 10, 1–9.
   PubMedGoogle Scholar
• PRISTON, M. J., and SEWELL, G. J., 1994, Improved LC assay for the determination of mitozantrone in plasma: analytical considerations. Journal of Pharmaceutical and Biomedical Analysis, 12, 1153–1162.
   PubMedGoogle Scholar
• RENTSCH, K. M., SCHWENDENER, R. A., and HANSELER, E., 1996, Determination of mitoxantrone in mouse whole blood and different tissues by high-performance liquid chromatography. Journal of Chromatography, 679, 185–192.
   Google Scholar
• Roos, G., 1987, Mitoxantrone sensitivity of human hematopoietic cell lines. Leukemia Research, 11, 519–524.
   PubMedGoogle Scholar
• RUBINO, 0. P., KOWALSKY, R., and SWARBRICK, J., 1993, Albumin microspheres as a drug delivery system: relation among turbidity ratio, degree of cross-linking, and drug release. Pharmaceutical Research, 10, 1059–1064.
   Google Scholar
• SHEU, M. T., and SoKowsKI, T. D., 1986, Entrapment of bioactive compounds within native albumin beads: III. evaluation of parameters affecting drug release. Journal of Parenteral Science Technology, 40, 259–265.
   PubMedGoogle Scholar
• SINGH, J., SINGH, R. P., KARUNAKAR, S., and TRIPATI, K. P., 1994, Preparation, characterization and in vitro release kinetics of aminophylline loaded albumin microspheres. Pharmaceutical Industry, 56, 1076–1080.
   Google Scholar
• SUNDMAN-ENGBERG, B., TIDEFELT, U., GRUBER, A., and CHRISTER, P., 1993, Intracellular concentrations of mitoxantrone in leukemic cells in vitro vs in vivo. Leukemia Research, 17, 347–352.
   PubMedGoogle Scholar
• TORRADO, J. J., ILLum, L., and DAVIS, S. S., 1989, Particle size and distribution of albumin microspheres produced by heat and chemical stabilization. International Journal of Pharmaceutics, 51, 85–93.
   Google Scholar
• TRAGANOS, F., EVENSON, D. P., STAIANO-COICO, L., DARZYNKIEWICZ, Z., and MELAMED, M. R., 1980, Action of dihydroxyanthraquinone on cell cycle progression and survival of a variety of cultured mammalian cells. Cancer Research, 40, 671–678.
   Google Scholar
• VURAL, I., KAS, H. S., HNCAL, A. A., and CAVE, G., 1990, Cyclophosphamide loaded albumin microspheres II. Release characteristics. Journal of Microencapsulation, 7, 511–516.
   PubMedGoogle Scholar
• VYAS, S. P., BHATNAGAR S., GOGOI, P. J., and JAIN, N. K., 1991, Preparation and characterization of HSA-propranolol microspheres for nasal administration. International Journal of Pharmaceutics, 69, 5–12.
   Google Scholar